tizanidine
- Product NDC
- 70934-021
- 11-digit product format
- 709340021
- Labeler code
- 70934
- Product ID
- 70934-021_a4e9ffd6-8a36-d8d6-e053-2a95a90a0af3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2020-04-10
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-021-30 | 70934002130 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-021-30) | 30 tablet | 2020-04-10 | 0000-00-00 | No | No | Current |
| 70934-021-90 | 70934002190 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-021-90) | 90 tablet | 2020-04-10 | 0000-00-00 | No | No | Current |